Poisoned Cough Syrups: World Health Body, NAFDAC Issue Public Alert.
The news of poisoned cough syrups in circulation, with all its clear health dangers is causing stirs in medical and family circles.
It has also made relevant regulatory bodies to forewarn parents and healthcare industry professionals to be on the alert.
Rumours over the Poisoned Cough Syrups in circulation has made the World Health Organisation (WHO) to issue what it calls a Medical Product Alert.
WHO says the concerns centre on three substandard (contaminated) oral liquid medicines containing active ingredients commonly used to relieve symptoms of the common cold, flu, or cough.
Although identified in India and reported to WHO on 8 October 2025, there are fears that without proper recall, and poisoned cough syrups may find their way to other countries, which receive medicine and drugs supplies from India.
The Eagle reports that last May, the National Agency for Food and Drug Administration and Control (NAFDAC) said it was in receipt of information regarding substandard drugs from the India authorities, following result of analyzed drug samples picked from sales/distribution point.
NAFDAC not only listed the affected drugs, but affirmed that some of the affected pharmaceutical companies were reported to have subsidiaries, partners and products in Nigeria.
“Administering substandard medicines poses significant risks to patient health and public health.
“These risks include poisoning, treatment failure, drug resistance, and even death. Substandard medicines may contain toxic substances, incorrect ingredients, or incorrect dosages, leading to severe adverse effects”, NAFDAC warned.
The news of poisoned cough syrups in circulation, with all its clear health dangers is causing stirs in medical and family circles.
It has also made relevant regulatory bodies to forewarn parents and healthcare industry professionals to be on the alert.
Rumours over the Poisoned Cough Syrups in circulation has made the World Health Organisation (WHO) to issue what it calls a Medical Product Alert.
WHO says the concerns centre on three substandard (contaminated) oral liquid medicines containing active ingredients commonly used to relieve symptoms of the common cold, flu, or cough.
Although identified in India and reported to WHO on 8 October 2025, there are fears that without proper recall, and poisoned cough syrups may find their way to other countries, which receive medicine and drugs supplies from India.
The Eagle reports that last May, the National Agency for Food and Drug Administration and Control (NAFDAC) said it was in receipt of information regarding substandard drugs from the India authorities, following result of analyzed drug samples picked from sales/distribution point.
NAFDAC not only listed the affected drugs, but affirmed that some of the affected pharmaceutical companies were reported to have subsidiaries, partners and products in Nigeria.
“Administering substandard medicines poses significant risks to patient health and public health.
“These risks include poisoning, treatment failure, drug resistance, and even death. Substandard medicines may contain toxic substances, incorrect ingredients, or incorrect dosages, leading to severe adverse effects”, NAFDAC warned.
Poisoned Cough Syrups: World Health Body, NAFDAC Issue Public Alert.
The news of poisoned cough syrups in circulation, with all its clear health dangers is causing stirs in medical and family circles.
It has also made relevant regulatory bodies to forewarn parents and healthcare industry professionals to be on the alert.
Rumours over the Poisoned Cough Syrups in circulation has made the World Health Organisation (WHO) to issue what it calls a Medical Product Alert.
WHO says the concerns centre on three substandard (contaminated) oral liquid medicines containing active ingredients commonly used to relieve symptoms of the common cold, flu, or cough.
Although identified in India and reported to WHO on 8 October 2025, there are fears that without proper recall, and poisoned cough syrups may find their way to other countries, which receive medicine and drugs supplies from India.
The Eagle reports that last May, the National Agency for Food and Drug Administration and Control (NAFDAC) said it was in receipt of information regarding substandard drugs from the India authorities, following result of analyzed drug samples picked from sales/distribution point.
NAFDAC not only listed the affected drugs, but affirmed that some of the affected pharmaceutical companies were reported to have subsidiaries, partners and products in Nigeria.
“Administering substandard medicines poses significant risks to patient health and public health.
“These risks include poisoning, treatment failure, drug resistance, and even death. Substandard medicines may contain toxic substances, incorrect ingredients, or incorrect dosages, leading to severe adverse effects”, NAFDAC warned.
0 Comentários
·0 Compartilhamentos
·750 Visualizações
